AREC.L
Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headqua...[Read more]
Industry
Biotechnology
IPO Date
2021-06-03
Stock Exchange
LSE
Ticker
AREC.L
According to Arecor Therapeutics plc’s latest financial reports and current stock price. The company's current PE Ratio is -3.48. This represents a change of 67.15% compared to the average of -2.08 of the last 4 quarters.
The mean historical PE Ratio of Arecor Therapeutics plc over the last ten years is -19.30. The current -3.48 PE Ratio has changed 1.70% with respect to the historical average. Over the past ten years (40 quarters), AREC.L's PE Ratio was at its highest in in the May 2017 quarter at 0. The PE Ratio was at its lowest in in the November 2017 quarter at -29.93.
Average
-19.30
Median
-14.93
Minimum
-59.86
Maximum
0
Discovering the peaks and valleys of Arecor Therapeutics plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.23%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -59.86
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.40 | -63.25% |
| 2023 | -6.53 | -12.88% |
| 2022 | -7.50 | -49.78% |
| 2021 | -14.93 | -38.64% |
| 2020 | -24.34 | -20.45% |
| 2019 | -30.60 | 11.23% |
| 2019 | -27.51 | -54.04% |
| 2018 | -59.86 | -Infinity% |
The current PE Ratio of Arecor Therapeutics plc (AREC.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.48
5-year avg
-11.14
10-year avg
-19.30
Arecor Therapeutics plc’s PE Ratio is greater than Poolbeg Pharma PLC (-3.59), less than Novacyt S.A. (-1.71), less than Aptamer Group plc (-1.45), greater than Sareum Holdings plc (-4.03), less than Renalytix Plc (-0.93), greater than Hemogenyx Pharmaceuticals Plc (-7.14), greater than Fusion Antibodies plc (-13.65), less than Genflow Biosciences plc (-3.05), greater than OptiBiotix Health Plc (-35.65), greater than IXICO plc (-6.61),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.59 | N/A | |
| -1.71 | N/A | |
| -1.45 | N/A | |
| -4.03 | N/A | |
| -0.93 | N/A | |
| -7.14 | N/A | |
| -13.65 | N/A | |
| -3.05 | N/A | |
| -35.65 | N/A | |
| -6.61 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arecor Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arecor Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Arecor Therapeutics plc's PE Ratio?
How is the PE Ratio calculated for Arecor Therapeutics plc (AREC.L)?
What is the highest PE Ratio for Arecor Therapeutics plc (AREC.L)?
What is the 3-year average PE Ratio for Arecor Therapeutics plc (AREC.L)?
What is the 5-year average PE Ratio for Arecor Therapeutics plc (AREC.L)?
How does the current PE Ratio for Arecor Therapeutics plc (AREC.L) compare to its historical average?